CMR Surgical unveils Versius update
It has launched vLimeLite – a new imaging technology to visualise ICG, (Indocyanine green), which will give surgeons enhanced visualisation, where indicated.
It is the first in a series of proposed 2024 product releases as part of Versius Plus which becomes the first CE marked surgical robot on the market to offer an integrated ICG system with multiple viewing modes and colour displays to visualise ICG – enhancing visualisation during surgery.
Surgeons at Gloucestershire Hospitals NHS Foundation Trust in the UK are the first to install vLimeLite. They will be able to use vLimeLite to help perform visual assessment of the vessels, blood flow and related tissue perfusion, as well as biliary anatomy.
vLimeLite is unique in surgical robotics because it is an integrated ICG system that allows visualisation of ICG with a choice of viewing mode for surgeons: overlay in full colour or greyscale. It also allows a choice of ICG colour: green or cyan.
Supratim Bose, CMR Surgical’s CEO said: “With 3D HD visualisation, surgeons already have a fantastic view of their operating field at our Versius console. But now, with vLimeLite they can see beyond what the eye can see, allowing them to clearly visualise critical anatomy during their operations.
“This is the most significant update of Versius since it launched back in 2019. We have listened to the needs of surgeons and I’m delighted that we have been able to give them what they want – a best-in-class ICG product that we know will make a real difference for their patients.”
Mark Slack, Chief Medical Officer and Co-Founder of CMR Surgical, added: “I think what is really special is the overlay mode option, which means Versius surgeons will be able to use our integrated ICG system, while continuing to view in full colour with the same video quality. vLimeLite truly allows surgeons to see what was once invisible to them.”
Steve Hornby and Simon Higgs, Consultant Upper GI Surgeons at Gloucestershire Hospitals NHS Foundation Trust who will be the first to operate with vLimeLite, have completed more than 200 cases with Versius at Gloucester Royal Hospital.
vLimeLite is initially launching in UK, Ireland and Hong Kong. A global rollout of vLimeLite will follow, subject to local regulatory approvals and there will be further product launches as part of Versius Plus throughout 2024.
The launch of vLimeLite follows CMR’s announcement that Q4 2023 was its strongest quarter on record, with more installations of Versius around the world, and the highest number of procedures undertaken by surgeons.